Navigation Links
CMC Biologics Highlights Technical Acumen at Upcoming Conferences
Date:4/16/2012

COPENHAGEN and SEATTLE, April 16, 2012 /PRNewswire/ -- CMC Biologics is a leading contract manufacturing organization (CMO) known and respected for its technical excellence in process development and cGMP manufacture of the most complex molecules (blood factors, coagulation factors, growth factors), as well as monoclonal antibodies. CMC Biologics' achievements are based on comprehensive analytical and characterization capabilities, expertise in continuous perfusion systems and single-use (disposable) technologies, and always in full compliance with the most current regulatory requirements and expectations.

(Logo: http://photos.prnewswire.com/prnh/20110502/SF93356LOGO)

"CMC Biologics is continually innovating to advance biopharmaceutical manufacturing to the next level. Our expertise in cGMP process development and manufacturing puts our clients' projects in an optimal position to succeed," said Gustavo Mahler, Chief Operations Officer for the company. "The opportunity to showcase our knowledge at several upcoming symposia helps to drive improvements in bioprocessing and also keeps us current on industry trends and technologies that are critical to our success."

Highlighting its industry leadership position and technical expertise, CMC Biologics will present and exhibit at the following upcoming biopharmaceutical and biomanufacturing conferences.

Parenteral Drug Association (PDA) Annual Meeting 2012, Phoenix, AZ

Presentation Date and Time:  Tuesday, April 17, 2012 at 2:15 p.m.
Title:  Key Elements in Successful Outsourcing
Presenter:  Morten Munk, Vice President Business Development, Technology Specialist

Presentation Date and Time:  Tuesday, April 17, 2012 at 7:30 a.m.
Title:  Quality and Regulatory Job Market Outlook 2012
Presenter:  Morten Munk, Vice President Business Development, Technology Specialist

CMC Biologics is exhibiting at Booth 314.  Stop by to learn about our regulatory and quality systems expertise.

Single Use Systems Workshop, Phoenix, AZ

Presentation Date and Time:  Wednesday, April 18, 2012 at 1:30 p.m.
Title:  Introduction to the Single-Use Technical Report which is used as a PDA Guideline for Implementation of Single-Use Equipment in Bio-Processing
Presenter:  Morten Munk, Vice President Business Development, Technology Specialist, and   Co-Chair, Program Planning Committee

Presentation Date and Time:  Wednesday April 18, 2012 at 1:30 p.m.
Title:  Design, Construction, Start-up and Operation of a Single-Use Clinical cGMP Manufacturing Facility
Presenter:  Andy Walker, Vice President Process Development 

Engineering Conference International, Cell Culture Engineering XIII, Scottsdale, AZ 

Presentation Dates:  April 22 – 27, 2012
Poster Title:  Implementation of 3L Disposable Reactors for Use as a Direct Scale-Up for cGMP Manufacturing
Poster Presenter:  Howard Clark, Director Development Upstream Process Development

2012 Thermo Scientific BioProcessing Technology Seminar Series, Bellevue WA

Presentation Date:  May 10, 2012, Bellevue, WA
Join us for the kick-off event of a multi-city discussion on the latest trends in Cell Culture and Bioprocessing, followed by a CMC Biologics manufacturing facility tour and special reception.  Leading industry experts in biomanufacturing will bring you advancements in cell culture media, single-use technology, and bioprocess manufacturing best practices. See the complete schedule for the full seminar schedule.
Presenter:  Gustavo Mahler, Chief Operations Officer

R3 Nordic Society of Cleanroom Technology, Copenhagen, Denmark

Presentation Dates:  May 14 – 15, 2012
Abstract Title:  Advantages of Single Use Bioreactors vs. Conventional Steel Bioreactors
Presenter:  Ronni Glenn Refstrup Hansen, Manager Cell Culture Manufacturing

60th American Society for Mass Spectrometry (ASMS) Conference on Mass Spectrometry and Allied Topics, Vancouver, BC, Canada

Presentation Dates:  May 20 – 24, 2012
Poster Title:  Protein Therapeutics: Structural Characterization, A simple strategy to perform parallel mAb disulfide bond assignment and polypeptide sequence confirmation
Presenter:  Xian Huang, Senior Development Scientist, Analytical and Formulation Development

2012 American Association of Pharmaceutical Scientists (AAPS) National Biotechnology Conference, San Diego, CA

Exhibition Dates:  May 21 – 22, 2012
CMC Biologics will be exhibiting at Booth P504.  Stop by to learn about our comprehensive Analytical Formulation and Stability standalone services offering.

IBC Life Sciences Single Use Applications Conference, San Francisco, CA

Presentation Date and Time:  Monday, June 4, 2012 at 11:25 a.m.
Title:  What is the Progress towards Harmonization of Standards and Best Practice for E&L? How Should/Does the Industry Qualify, Test, Validate, Engineer and Set Standards for Single-Use Applications?
Presenter:  Morten Munk, Vice President Business Development, Technology Specialist

Presentation Date and Time:  Tuesday, June 5, 2012 at 3:00 p.m.
Case Study:  Scale-Up Into and Implementation of a 2000 Liter Single-Use Bioreactor in an Existing cGMP Facility – Lessons Learned
Presenter:  Andy Walker, Vice President Process Development 

2012 Biotechnology Industry Organization (BIO) International Annual Convention, Boston, MA

Exhibition Dates:  June 18 – 21, 2012
CMC Biologics will be exhibiting at Booth 664 in the Bioprocessing Zone.  Stop by to learn about us and enjoy special Seattle and Copenhagen coffee, food and wines throughout the exhibit.

For questions or additional details, please contact Stacie Byars, Senior Manager Global Marketing, at sbyars@cmcbio.com.

About CMC Biologics

CMC Biologics is a leading contract development and manufacturing organization that provides fully integrated biopharmaceutical development and manufacturing solutions to clients around the world, from its facilities in Europe and the USA.  The company has proven expertise in delivering custom solutions for the scale-up and cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials and in-market production.  The company's wide range of integrated services includes cell line development, bioprocess development, formulation and comprehensive analytical testing.  Clients can also benefit from CMC Biologics' proprietary CHEF1® expression system for mammalian production.  CMC Biologics has fully segregated microbial fermentation and mammalian cell culture suites and offers both fed-batch and perfusion production processes.  CMC Biologics is located in Copenhagen, Denmark, and Seattle, Washington. Visit www.cmcbio.com  to learn more.


'/>"/>
SOURCE CMC Biologics
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. DSM Biologics and MorphoSys AG to Manufacture Fully Human Antibody
2. Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy
3. Therapure Biopharma Inc. announces collaboration with Induce Biologics Inc.
4. Savient Submits Biologics License Application (BLA) for pegloticase
5. DSM Biologics and Crucell Announce Commercial PER.C6(R) Licensing Agreement with Gedeon Richter
6. Interface Biologics secures $5mm financing and appoints Thomas P. Reeves President and Chief Executive Officer
7. Insmed Sells Follow-on Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million
8. FDA Accepts Amgens Submission and Files Biologics License Application for Denosumab
9. Bone Biologics Announces UCB-1 (NELL-1) Bone Growth Protein Production Process With Aragen Biosciences
10. Frost & Sullivan Recognizes ApaTechs Leadership in Orthopedic Biologics
11. LaVoie Group Adds Bio-Surgery Company, Pegasus Biologics, to Its Life Sciences Agency Roster
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... NEW YORK , March 23, 2017 ... closer look at four equities in the Biotech industry: ... EYEG), Synthetic Biologics Inc. (NYSE MKT: SYN), and Regulus ... March 21 st , 2017, Credit Suisse upgraded its rating ... stocks by downloading their free report at: ...
(Date:3/22/2017)... 22, 2017  UBM and the Massachusetts Medical ... extended partnership and the third annual Massachusetts Medtech Week. ... 21 st Annual MassMEDIC Conference held in ... 3-4, 2017. MassMEDIC will feature ... President and CEO, Scott Whitaker , at ...
(Date:3/22/2017)... March 22, 2017 MarketNewsUpdates.com News Commentary  ... The ... are being pressured as of late due to the rise ... management has a dramatic impact on patient,s quality of life ... activities for identifying new forms of opioid formulations that prevent ...
(Date:3/22/2017)... ... March 21, 2017 , ... Okyanos Cell Therapy has announced Tallahassee, FL will ... events series, “Stem Cell Therapy: The Next Phase in the Evolution of Medicine.” As ... Cell Research and Therapy Act, Okyanos maintains a mission to help “no-option” patients ...
Breaking Biology Technology:
(Date:3/2/2017)... 2, 2017 Summary This report ... Merck KGaA and its partnering interests and activities since ... Description The Partnering Deals and Alliance since 2010 ... of one of the world,s leading life sciences companies. ... purchase to ensure inclusion of the most up to ...
(Date:3/2/2017)... 2017 Australian stem cell and regenerative medicine ... signed an agreement with the Monash Lung Biology Network, ... Institute and Department of Pharmacology at Monash University, ... study to support the use of Cymerus™ mesenchymal stem ... Asthma is a chronic, long term lung condition ...
(Date:2/28/2017)... 2017   Acuant , a leading provider of ... enhancements to new and core technologies building upon the ... mobile and desktop Acuant FRM TM facial recognition ... real time manual review of identity documents by accredited ... fastest and most accurate capture software to streamline workflows ...
Breaking Biology News(10 mins):